Core Insights - INVL Baltic Sea Growth Fund has sold its entire stake in MBL Group to MidEuropa, marking the fund's second exit and enabling full repayment to investors [1][2] - MBL is a leading European contract development and manufacturing organization (CDMO) specializing in assisted mobility, rehabilitation, and aged-care equipment, with significant growth in EBITDA since INVL's investment [2][3] - The transaction is seen as a strong endorsement of MBL's business model and long-term potential, with the Lauritsen family reinvesting and Martin Lauritsen continuing as CEO [1][3] Company Overview - MBL, founded in 1988 by the Lauritsen family in Denmark, is the largest European CDMO for medical mobility devices, employing approximately 1,700 professionals across Europe and Asia [2][3] - The company has over 100 registered patents and is recognized for its innovation capabilities, with projected revenue exceeding EUR 120 million by 2025 [2][3] Investment Context - The assisted mobility market is expected to grow due to factors such as population aging and increasing prevalence of chronic conditions, which aligns with MBL's strategic focus [3] - MidEuropa, a leading European private equity investor, aims to support MBL's growth and international expansion, emphasizing the investment's strong fundamentals and long-term growth potential [3][6] Fund Background - INVL Baltic Sea Growth Fund, with a size of EUR 165 million, is one of the leading private equity funds in the Baltics, backed by the European Investment Fund [4] - The fund is managed by INVL Asset Management, which has over 30 years of experience and manages more than EUR 2 billion in various investment strategies [4][5] Transaction Details - The transaction was advised by Jefferies International, with legal, financial, and commercial support from Horten, Deloitte, and L.E.K. respectively [3]